Alex Friedlaender

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 8

Top Topics

Cerebrospinal Fluid

Squamous Cell Carcinoma

Brain Metastases

Top Venues

Exploration of targeted anti-tumor therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Floryane Kim, Maxime Borgeaud, Alfredo Addeo, Alex Friedlaender
Management of stage III non-small-cell lung cancer: rays of hope. Exploration of targeted anti-tumor therapy 5 (1) (2024)
Gina Colarusso, Hiba Mechahougui, Thibaud Koessler, Alex Friedlaender
Metastatic gastric cancer: synergizing and sequencing targeted therapy with first-line immunotherapy. Immunotherapy (2024)
Floryane Kim, Maxime Borgeaud, Alfredo Addeo, Alex Friedlaender
Management of stage III non-small-cell lung cancer: rays of hope. Exploration of targeted anti-tumor therapy 5 (1) (2024)
Gina Colarusso, Hiba Mechahougui, Thibaud Koessler, Alex Friedlaender
Metastatic gastric cancer: synergizing and sequencing targeted therapy with first-line immunotherapy. Immunotherapy 16 (7) (2024)
Gina Colarusso, Hiba Mechahougui, Thibaud Koessler, Alex Friedlaender
Metastatic gastric cancer: synergizing and sequencing targeted therapy with first-line immunotherapy. Immunotherapy 16 (7) (2024)
Alfredo Addeo, Giuseppe Luigi Banna, Alex Friedlaender
KRAS G12C Mutations in NSCLC: From Target to Resistance. Cancers 13 (11) (2021)
Laure Thouvenin, Timothée Olivier, Giuseppe Banna, Alfredo Addeo, Alex Friedlaender
Immune checkpoint inhibitor-induced aseptic meningitis and encephalitis: a case-series and narrative review. Therapeutic advances in drug safety 12 (2021)
Alex Friedlaender, Alexander E Drilon, Giuseppe Luigi Banna, Solange Peters, Alfredo Addeo
The METeoric rise of MET in lung cancer. Cancer 126 (22) (2020)